Faster Response to IV vs Intranasal Ketamine in Depression

NEW ORLEANS – New research reveals that patients with treatment-resistant depression who were treated with repeated intravenous differences ketamine show no significant in achieving response or remission, compared with those receiving the intranasal formulation of the drug, esketamine – although fewer treatments appear necessary with the intravenous formulation. Dr Balwinder Singh “This is one of … Read more